In the context of PDAC, SIRT6 elevates the expression of pro-inflammatory cytokines and chemokines, such as IL-8 and TNF, thereby fostering an inflammatory phenotype in pancreatic cancer cells. Here, SIRT6 is linked to pancreatic neoplasm.